Research, Studies & Clinical Trials

 

Non-Hormonal Birth Control: Studying two different types of Copper IUDs

Full Title A multi-center, single-blind, randomized clinical trial to compare two copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard
Short Title Non-hormonal birth control: studying two different types of copper IUDs
COMIRB # Chesapeake IRB – 17-0225
Description Study of two copper IUDs: One which is FDA approved, ParaGard, and another which is approved and used in Europe, Mona Lisa.
Who is eligible Women between the ages of 18-40 who pass clinical lab criteria.
Compensation provided Yes
Primary Investigator Dr. Stephanie Teal
Sponsor FHI 360 & NIH
Contact Lisa Powers, email or call 303-724-5284

 

Research about the Effect of Isotretinoin (acne medication) on the Etonogestrel Contraceptive Implant (Implanon®/Nexplanon®)

Full Title The effect of isotretinoin on the etonogestrel contraceptive implant.
Short Title Isotretinoin-Implant
COMIRB # 16-0614
Description  Participation will last up to 20 weeks. Blood will be drawn at the beginning of the study and at two subsequent study visits: 4 and 9 weeks after enrollment. You will be called 20 weeks after enrollment for a brief telephone interview. You must have a birth control implant in place to qualify for the study.
Who is eligible Are you a healthy woman between the ages of 18-45? Are you currently under the care of a Dermatologist and considering starting treatment with isotretinoin (Accutane®)? Do you currently have the birth control implant (Implanon®/Nexplanon®) or are you planning to use the birth control implant during isotretinoin (Accutane®) therapy?
Compensation provided Yes
Primary Investigator Dr. Aaron Lazorwitz
Sponsor None
Contact Rebecca Seale, email or call 303-724-2013

 

Fertility patch study for women who have never had a menstrual period

Full Title A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered via OmniPod Pump for Ovulation Induction in Female Subjects with Primary Amenorrhea with Hypogonadotropic Hypogonadism
Short Title LutrePulse OmniPod Hypo Hypo Study
COMIRB # Western IRB – 13-352
Description Study of a possible fertility patch for women who are hypo hypo (never had a menstrual period)
Who is eligible Women with Hypo Hypo who pass clinical lab criteria.
Compensation provided Yes
Primary Investigator Dr. Nanette Santoro
Sponsor Ferring Pharmaceuticals
Contact Celeste Robledo, email or call 303-724-2013

 

Birth Control Hormone Therapy for Perimenopause Treatment Research Study

Full Title Effectiveness of Perimenopausal Hormone Therapy in Suppression of Ovulation, Stabilization of Reproductive Hormones, and Symptom Control
Short Title Bayer-Perimenopausal
COMIRB # 11-1711
Description Study to determine effectiveness of perimenopausal hormone therapy (Mirena intrauterine device alone and in conjunction with estradiol gel) in suppression of ovulation, stabilization of reproductive hormones, and symptom relief in perimenopausal women
Who is eligible Women ages 40–52 with regular periods and any of the following symptoms of perimenopause

  • Hot flashes
  • Cyclical bloating, mood changes or headache
  • Trouble sleeping
Compensation provided Yes
Primary Investigator Dr. Nanette Santoro
Sponsor Bayer Corporation
Contact Christina Gavito, email or call 303-501-4157

 

Contraceptive Vaginal Ring Research Study

Full Title A multicenter, open-label randomized study on the efficacy, cycle control and safety of a contraceptive vaginal ring delivering a daily dose of Nestorone® and estradiol (NES-E2 CVR).
Short Title Contraceptive Vaginal Ring Study
COMIRB # 18-0226
Description The purpose of this research study is to test the effectiveness of an investigational contraceptive vaginal ring.
Who is eligible If you are a woman between the ages of 18 and 35, are pre-menopausal, sexually active and do NOT wish to become pregnant, you are invited to see if you may qualify for a research study.
Compensation provided Yes
Primary Investigator Dr. Stephanie Teal
Sponsor NICHD & Population Council
Contact Lisa Powers, email or call 303-724-5284

Topiramate and Contraceptive Implant Research Study

Full Title The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users.
Short Title Topiramate and Contraceptive Implant
COMIRB # 17-1047
Description Research on the effect of Topiramate, a medication used for migraines and seizure disorders, on the contraceptive implant.
Who is eligible Are you a healthy woman between the ages of 18-45? Do you currently have the birth control implant (Nexplanon®) and have used it between 12 and 36 months? Are you willing to take a study drug (topiramate) for 6 weeks?
Compensation provided Yes
Primary Investigator Dr. Stephanie Teal
Sponsor Merck
Contact Lisbel Torres, email or call 303-724-3514

 

 Contact Our Research Staff 

Our Research Staff

Family Planning research staff

Email: [email protected]

Study Cell 1: (303) 501-4157

Study Cell 2: (720) 505-7413


OB/GYN research staff

Sandra Cano, MA

Sandra_Cano-Saved-for-Web

Email: [email protected]

Direct: (303) 724-2013

Study Cell: (720) 505-7413

Fax: (303) 724-2062

Ines Crato

Ines Crato | University of Colorado

Email: [email protected]

Direct: (303) 724-5559

Fax: (303) 724-2062

Eva Dindinger

Eva Dindinger | University of Colorado

Email: [email protected]

Direct: (303) 724-8482

Study Cell: (303) 505-7413

Fax: (303) 724-2062

Christina Gavito, BA

Christina_Gavito-Saved-for-Web

Email: [email protected]

Direct: (303) 724-5559

Pager: (303) 266-0252

Fax: (303) 724-2062


Cricket McHugh, BS

Cricket_McHugh_Saved-for-Web

Email: [email protected]

Direct: (303) 724-5284

Study Cell: (303) 501-4157

Fax: (303) 724-2062

Marissa Peters, MPH

Marissa_Peters_Saved-for-Web

Email: [email protected]

   

Rebecca Seale

Rebecca Seale | University of Colorado

Email: [email protected]

Direct: (303) 724-2013

Fax: (303) 724-2062

Maryke Swartz

Maryke_Swartz-Saved-for-Web

Email: [email protected]

Direct: (303) 724-8482

Fax: (303) 724-2062